DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMII) Operating cash flow
DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMII) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.0MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMII financial trends
DMII RevenueDMII Net incomeDMII Net marginDMII Gross profitDMII Gross marginDMII Operating incomeDMII Operating marginDMII Free cash flowDMII Capital expendituresDMII Return on equityDMII Stock buybacksDMII Dividends paidDMII Total assetsDMII Total liabilitiesDMII Shareholders’ equityDMII overview →